Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
3,935
+11
+0.3% +$582 0.01% 741
2026
Q1
$219K Sell
3,924
-731
-16% -$39.6K 0.01% 676
2025
Q4
$228K Buy
+4,655
New +$217K 0.01% 663
2025
Q3
Sell
-5,435
Closed -$209K 750
2025
Q2
$209K Buy
+5,435
New +$208K 0.01% 677
2022
Q3
Sell
-5,838
Closed -$320K 489
2022
Q2
$320K Buy
5,838
+599
+11% +$33.1K 0.03% 371
2022
Q1
$288K Sell
5,239
-3,461
-40% -$188K 0.02% 410
2021
Q4
$485K Sell
8,700
-2,081
-19% -$108K 0.07% 225
2021
Q3
$522K Sell
10,781
-244
-2% -$12.3K 0.07% 250
2021
Q2
$556K Buy
11,025
+110
+1% +$5.29K 0.07% 247
2021
Q1
$496K Buy
+10,915
New +$495K 0.06% 257

Other funds holding GSK

Focus Financial Network's GSK Position: Q2 2026 in Review

Focus Financial Network increased its GSK (GSK) stake by 0.28% in Q2 2026, buying an estimated $582 and bringing the position to 3,935 shares worth $206K. The position accounts for 0.01% of the portfolio, ranked #741.

Focus Financial Network first reported a position in GSK in Q1 2021 and has held it in 10 quarters since. The position peaked at $556K in Q2 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Focus Financial Network held 3,935 shares of GSK worth $206K as of Q2 2026.
  • Focus Financial Network bought 11 GSK shares in Q2 2026, an estimated $582.
  • GSK made up 0.01% of Focus Financial Network's portfolio in Q2 2026, its #741 holding.
  • Focus Financial Network first reported a position in GSK in Q1 2021 and has held it in 10 quarters since.
  • Focus Financial Network's GSK position peaked at $556K in Q2 2021.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.